I’m a 78-year old man who was diagnosed with asthma about 10 years ago, after a severe coughing attack left me unable to ...

The FDA’s approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu vaccines. On August 5, the US Food and Drug Administration approved ...

The treatment can reprogram immune cells that have been corrupted by the cancer, strengthening the body’s ability to attack. Our immune systems don’t just fight bacteria and viruses invading the body.

With flu season approaching, Board of Health member Dr. Amanda Ritvo urged residents Monday to get vaccinated against influenza and outlined new state guidance for COVID-19 shots, saying September and ...

This article originally appeared on the Bloomberg School of Public Health website. An mRNA flu vaccine is on its way. On Aug. 5, the U.S. Food and Drug Administration approved Moderna's mFLUSIVA, the ...

An estimated 2.1 million new cancer cases will be diagnosed in the United States this year and an estimated 626 thousand will die, according to the American Cancer Society. However, there may be hope ...

Trial stopped after review deems it unlikely to succeed Separate study for pancreatic cancer patients to continue Setback comes after Merck-Moderna's recent success in melanoma patients U.S.-listed ...

Share on Pinterest Moderna’s new mRNA flu vaccine has been approved by the FDA for adults ages 50 years and older. FatCamera, E+/Getty Images The Food and Drug Administration (FDA) has approved ...

Professor Jeremy Sanford chairs the Department of Molecular, Cell, & Developmental Biology and co-directs the RNA Center at UC Santa Cruz. The U.S. Food and Drug Administration’s approval of the first ...

Moderna is touting a "landmark moment" in its experimental melanoma treatment, saying its vaccine could help prevent the deadly skin cancer from returning or spreading. The groundbreaking clinical ...

Moderna and Merck have announced that a personalised mRNA cancer vaccine called Intismeran reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...